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Purpose: The purpose of this study was to review the clinical experiences of scleritis and episcleritis in
Southern Taiwanese people during a 7-year period.
Methods: The charts of 89 patients (representing 101 eyes) who had visited our clinic from January 2003
to July 2010 were retrospectively reviewed. They were diagnosed as having episcleritis or scleritis. The
medical charts, slit lamp photographs, and laboratory data were reviewed. Age, gender, laterality, pre-
vious surgery history, systemic diseases, follow-up duration, and ocular complications were collected.
The patients were classiﬁed as having clinically suspected noninfectious scleritis (CSNIS), clinically
suspected infectious scleritis (CSIS), and episcleritis for analysis.
Results: In the series of 89 patients (i.e., 101 eyes), 31 (34.8%; 32 eyes) patients had scleritis and 58
(65.2%; 69 eyes) patients had episcleritis. Episcleritis and scleritis occurred slightly more frequently
in women than in men. In the 31 patients (32 eyes) diagnosed with scleritis, 12 (38.7%) patients
had CSIS and 19 (61.3%) patients had CSNIS. Patients with scleritis were older than patients with
episcleritis (p < 0.001). Previous pterygium excision was associated with CSIS and necrotizing
scleritis.
Conclusion: Scleritis occurred in a more elderly population. It was more frequently associated with ocular
complications, compared to episcleritis. Both CSNIS and CSIS were associated with a history of pterygium
excisional surgery. Our series of patients had a high occurrence of necrotizing scleritis. All cases of
necrotizing scleritis were associated with a history of previous ocular surgery.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Scleritis is characterized by deep inﬂammation of the sclera that
can spread to the adjacent cornea, episclera, and uvea, and cause
sight-threatening complications.1e4 The ocular inﬂammation is
often severe, and sometimes requires treatment with systemic
immunosuppressive medications.4,5 Approximately 25e50% of
patients with scleritis have an associated systemic illness that is
presumably causally related.6 Comorbid systemic conditions that
have been associated with scleritis include rheumatoid arthritis,
Wegener's granulomatosis, systemic vasculitis, systemic lupus
erythematosis, sarcoidosis, and spondyloarthropathies.6e9 Epis-
cleritis, by contrast, is generally a less severe inﬂammationof interest.
logy, Kaohsiung Chang Gung
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ciety of Taiwan. Published by Elsevlocalized to the episclera. Unlike the deeper inﬂammation in
scleritis, episcleral inﬂammation is relatively superﬁcial and has the
characteristic color of bright red or salmon pink, whereas most
forms of scleritis present with a violaceous hue. Episcleritis often
responds well to topical corticosteroid treatment10 and seldom
causes ocular complications.1,9
In the United States, the overall incidence of episcleritis is
reportedly 41.0 per 100,000 person-years, and that of scleritis is 3.4
per 100,000 person-years; there is an increased prevalence among
the elderly and women.11
However, most previous reports were based on Western
populations with a distinctly different ethnic composition than
that in Taiwan. Furthermore, previously published reports of
scleritis from Taiwan mostly focused on scleral inﬂammation
caused by an infectious etiology12e16 rather than a full scope
investigation into both episcleritis and scleritis. Therefore, we
conducted this study to evaluate and analyze our experience of
the clinical features and etiologies of scleritis and episcleritis in
Southern Taiwan.ier Taiwan LLC. All rights reserved.
Table 1
Clinical characteristics of patients with episcleritis and scleritis.
Episcleritis
(n ¼ 58)
Scleritis
(n ¼ 31)
p
Age (y) 47.7 62.2 < 0.001
Sex (male:female) 28:30 12:19 0.39
Bilateral involvement 11 (19.0) 1 (3.2) 0.10
Ocular complications
Ocular hypertension 0 (0) 6 (19.4) < 0.01
Decreased VA 11 (19.0) 14 (45.2) 0.01
History of pterygium excision 2 (3.4) 18 (58.1) < 0.001
Follow-up duration (mo) 13.2 27.0 0.01
Systemic autoimmune disease 3 (5.2) 4 (12.9) 0.23
Rheumatoid arthritis 1 1
Ankylosing spondylitis 0 1
SLE 2 0
Sjogren's syndrome 0 1
Autoimmune thyroiditis 0 1
Nonautoimmune systemic
disease
14 (24.1) 8 (25.8) 0.86
Diabetes mellitus 5 2
Hypertension 7 4
Chronic hepatitis 6 2
Data are presented as n or n (%).
SLE ¼ systemic lupus erythematosus; VA ¼ visual acuity.
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Patients diagnosed as having episcleritis or scleritis from
January 2003 to July 2010 at the Cornea Service of Kaohsiung Chang
Gung Memorial Hospital, Kaohsiung, Taiwan were included in this
study. The medical records, slit lamp photography, and laboratory
data were reviewed. Patients without records of slit lamp photo-
graphs or whose photographs were of poor quality were excluded.
Age, gender, laterality, previous surgery history, systemic diseases,
follow-up duration, and ocular complications were recorded for
analysis. Ocular complications included: (1) visual acuity impair-
ment, deﬁned as a decrease in visual acuity of two Snellen lines or
more; and (2) ocular hypertension, deﬁned as intraocular pressure
higher than 21 mmHg. The presence of systemic diseases or auto-
immune diseases was recorded for analysis.
Classiﬁcation was based on the anatomic site and clinical
appearance of inﬂammation. Episcleritis was diagnosed when the
inﬂammation was localized and conﬁned to the episclera and
blanched after the instillation of topical 10% phenylephrine. Scler-
itis was deﬁned as the edema of the episcleral and scleral tissues
with congestion of the superﬁcial and the deep episcleral vessels.
Application of 10% phenylephrine to the ocular surface blanches the
superﬁcial episcleral vessels but not the deeper scleral vascular
plexus, thus differentiating between episcleritis and scleritis.
Patients with scleritis were divided into clinically suspected
noninfectious scleritis (CSNIS) and clinically suspected infectious
scleritis (CSIS). The former was further classiﬁed as “anterior
scleritis” or “posterior scleritis”, based on the anatomical location of
the inﬂammation. Thickening of the posterior sclera in posterior
scleritis was conﬁrmed by B-scan ultrasonography. Anterior scler-
itis was categorized as diffuse scleritis, nodular scleritis, or necro-
tizing scleritis. Diffuse scleritis was deﬁned as diffuse inﬂammation
and vascular engorgement of the episclera and sclera. Nodular
scleritis was characterized by an immobile elevated nodular
swelling and inﬂammation of the sclera. Patients who presented
with an avascular patch or ulcerative area on the sclera with or
withoutmarked inﬂammationwere classiﬁed as having necrotizing
scleritis.
Patients classiﬁed as having CSIS included: (1) patients with
infectious scleritis with positive isolation of the causative micro-
organism from the lesion, and (2) patients with suspected infec-
tious scleritis that showed favorable clinical response to antibiotic
treatment but without laboratory evidence of microbial growth.
The clinical picture of CSIS was acute inﬂammation of the sclera
with subconjunctival abscess and suppurative discharge. The
specimen for microbial culture was obtained from debridement
surgery or scleral scraping in the clinic. Common aerobic, common
anaerobic, fungus, and mycobacterial cultures were obtained.
Statistical analyses were performed using SPSS software version
17.0 (SPSS Inc., Chicago, IL, USA). Differences between the two
groups were compared and evaluated with the Student t test for
continuous variables and with the Chi-square test for categorical
variables. Analysis between multiple groups was evaluated with
one-way analysis of variance. A value of p < 0.05 was considered
statistically signiﬁcant.
3. Results
Eighty-nine patients (representing 101 eyes) diagnosed with
episcleritis or scleritis from January 2003 to July 2010 were
included in this study. Therewere 31 (34.8%) cases of scleritis with a
mean patient age of 62.2 ± 18.5 years, and 58 (65.2%) cases of
episcleritis with a mean patient age of 47.7 ± 17.3 years. Table 1
summarizes the clinical characteristics of the patients. There was
a slight female predominance in the episcleritis and scleritisgroups, and they accounted for more than one-half of the cases in
both groups (episcleritis, 52%; scleritis, 61%). The patients with
scleritis were signiﬁcantly older than patients with episcleritis
(p < 0.001). When the scleritis group was further divided into the
CSNIS group and CSIS group, we found that the CSIS patients were
older (CSNIS, 55.0 years old; CSIS, 73.7 years old).
Ocular complications were more common among the scleritis
patients than among the episcleritis patients. Blurred vision was
present in 45.2% of scleritis patients and 19.0% of episcleritis pa-
tients (p ¼ 0.01). Ocular hypertension was present in 19.4% of
scleritis patients, but was not present in any of the episcleritis pa-
tients (p < 0.01). None of the episcleritis patients progressed to
scleritis during the follow-up period.
Concomitant autoimmune disease was relatively low in our
series. Only 5.2% of episcleritis patients and 12.9% of scleritis pa-
tients had an associated autoimmune disease. In the episcleritis
group, there was one case of rheumatoid arthritis and two cases of
systemic lupus erythematosus. In the scleritis group, there was one
case each of rheumatoid arthritis, ankylosing spondylitis, autoim-
mune thyroiditis, and Sjogren's syndrome.
A history of previous pterygium excisional surgery was more
frequent in the scleritis group than in the episcleritis group
(p < 0.001). The proportion of patients with previous pterygium
excision was 75% in the CSIS group and approximately 47% in the
CSNIS group (Fig. 1). In the CSNIS group, most patients who had had
previous pterygium excision presented with anterior necrotizing
scleritis, which was the most common form of anterior scleritis in
our study (Table 2). In 20 patients in this series who had a history of
pterygium excision, nine (45%) patients presented with CSIS, eight
(40%) patients presented with anterior necrotizing scleritis, two
(10%) patients presented with episcleritis, and one (5%) patient
presented with anterior nodular scleritis.
In the subset of patients diagnosed with CSIS (n ¼ 12), nine
patients had a positive microbial culture. The most commonly
isolated microorganism was Pseudomonas aeruginosa in 6 (50%) of
12 patients, followed by fungus in 2 (12.5%) of 12 patients. Seventy-
ﬁve percent of patients had previous pterygium excision, whereas
one (8.3%) pterygium excisionwas associatedwith traumatic injury.
Except for one patient, all (91.6%) other patients, underwent sur-
gical debridement for subconjunctival abscess with scleral necrosis
(Table 3). The range of time from diagnosis to surgical debridement
Table 3
Summary of the clinical characteristics of patients with clinically signiﬁcant infec-
tious scleritis.
Case
No.
Sex Age Predisposing
factor
Surgical
debridement
Time from
diagnosis to
debridement
Culture
1 F 72 Pterygium
surgery
Yes 3 d No growth
2 F 68 Pterygium
surgery
Yes 3 d Pseudomonas
aeruginosa
3 M 73 Pterygium
surgery
No d No growth
4 F 87 Idiopathic Yes 10 d Haemophilus
inﬂuenza
5 F 75 Pterygium
surgery
Yes 5 d P. aeruginosa
6 M 75 Trauma Yes 23 d Fungus
7 M 68 Idiopathic Yes 30 d Fungus
8 F 76 Pterygium
surgery
Yes 45 d No growth
9 F 48 Pterygium
surgery
Yes 3 d P. aeruginosa
10 F 75 Pterygium
surgery
Yes 2 d P. aeruginosa
11 F 94 Pterygium
surgery
Yes 5 d P. aeruginosa
12 F 73 Pterygium
surgery
Yes 4 d P. aeruginosa
Fig. 1. The percentage of episcleritis and scleritis patients with a previous history of
pterygium excision. CSIS ¼ clinically signiﬁcant infectious scleritis; CSNIS ¼ clinically
signiﬁcant noninfectious scleritis. * Indicates a signiﬁcant statistical difference be-
tween episcleritis and CSNIS, and between episcleritis and CSIS (p < 0.001, based on
one-way analysis of variance).
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debridement surgery was performed mostly within 5 days after
diagnosis.
4. Discussion
Consistent with the results of previous studies,1,9e11 we found
an older age in the scleritis group and female predominance in the
scleritis and episcleritis groups. In a large cohort study by Sainz de
la Maza et al1 and an epidemiological study by Honik et al,11 the
reported mean age was 45.6e47.4 years for patients with epis-
cleritis and 52.6e53.7 years for patients with scleritis. In our study,
the mean age for patients with episcleritis was 47.7 years, which
was comparable to their results; however, the mean age in our
group of scleritis patients was 62.2 years, which is slightly older
than the age previously reported in the literature.1,11
Ocular complications are more frequently encountered in
scleritis and reportedly occurs in 29.4e84.6% of patients.1,4,9,10,17
These complications include loss in visual acuity, ocular hyper-
tension, anterior uveitis, peripheral ulcerative keratitis, cataract,
scleral thinning, and in severe cases involve the posterior segment,
cystoid macular edema or exudative retinal detachment. In our
study, 45.2% of scleritis patients presented with decreased vision.Table 2
Association between a history of previous pterygium excision and autoimmune
disease in patients with scleritis.
CSNIS (n ¼ 19) CSIS
(n ¼ 12)
Anterior
nodular
scleritis
(n ¼ 4)
Anterior
diffuse
scleritis
(n ¼ 5)
Anterior
necrotizing
scleritis
(n ¼ 8)
Posterior
scleritis
(n ¼ 2)
History of
pterygium
excision
1 (25) 0 (0) 8 (100) 0 (0) 9 (75)
Autoimmune
disease
1 (25) 1 (20) 0 (0) 1 (50) 1 (8.3)
Data are presented as n (%).
CSIS ¼ clinically signiﬁcant infectious scleritis; CSNIS ¼ clinically signiﬁcant
noninfectious scleritis.Sainz de la Maza et al1 found that predictive factors associated with
loss in visual acuity were the presence of anterior uveitis, ocular
hypertension, and the subtype of necrotizing scleritis. However, a
study by Jabs et al10 and a recent study by Wieringa et al4 found
that decreased visual acuity was associated with concomitant
systemic disease, but was not associated with the type of scleritis.
By comparison, episcleritis tends to be a milder ocular disorder
with fewer ocular complications and better responsiveness to
topical medications, compared to scleritis. Most cases of episcleritis
remain localized to the episclera and do not progress to scleritis.10
In our study, no patient diagnosed with episcleritis progressed to
scleritis within the follow-up period.
In this study, we found that the rate of associated autoimmune
disease was much lower than that previously reported. The sys-
temic disease association rate in scleritis had been reported as high
as 29.8e39.2%.1,4,7,9,10 However, in a more recent study, Honik
et al11 also reported a relatively low systemic disease rate of 1.2% in
episcleritis and 6% in scleritis in their epidemiologic study. Raiji and
coworkers8 in their community-based study on the association
between scleritis and systemic disease also pointed out that dif-
ferences in the reported rate of autoimmune diseases may be
largely inﬂuenced by the study population and the clinical setting
where the study is conducted. Because most previous studies have
been conducted at large tertiary university-based referral centers
where patients with more severe diseases are concentrated,
referral bias may have resulted in the high rate of disease
association.
Furthermore, previous studies have all been conducted on
Caucasian populations,1,4,7e10 which have all identiﬁed rheumatoid
arthritis as the most commonly associated systemic autoimmune
disease. In contrast to a Caucasian population, Cohen et al18 in their
study of 153 Chinese rheumatoid arthritis patients found that
extra-articular manifestation was relatively uncommon and that
the only extra-articular manifestations were rheumatoid nodules
(4.6%), episcleritis (0.7%), and cutaneous vasculitis (0.7%). In our
study, the association between rheumatoid arthritis and episcleritis
and scleritis was low with only one (1.7%) case of rheumatoid
arthritis in the episcleritis group and one (3.2%) case of rheumatoid
Y.-W. Chen et al. / Taiwan Journal of Ophthalmology 5 (2015) 19e2222arthritis in the scleritis group. Racial differences in ocular mani-
festations of systemic diseases may have likely also contributed to
the low autoimmune disease rate observed in our study.
Twenty (22.5%) patients in this case series had a previous his-
tory of pterygium excision on the diseased eye. In these patients,
the most common presentation was infectious scleritis (45%), fol-
lowed closely by necrotizing scleritis (40%). In a recent meta-
analysis, Liu et al19 reported a world-wide prevalence of 10.2% for
pterygiumwith an increasing prevalence in regions with a latitude
close to the equator. Signiﬁcant risk factors included old age, sun
exposure, and outdoor activity.19 In Taiwanese aborigines, the
prevalence of pterygium was as high as 44.1%.20 In Taiwan, pte-
rygium excisional surgery is common clinically, probably because
of the high prevalence of pterygium and easy medical access.
Several studies of infectious scleritis from Taiwan have previ-
ously been published.12e16 In these studies, pterygium surgery was
the most common inciting factor with Pseudomonas aeruginosa
being the most common microbe. Our study had both factors.
However, the association between pterygium surgery and
noninfectious necrotizing scleritis has been less reported in Taiwan.
Surgically induced necrotizing scleritis has typically been consid-
ered a rare complication after cataract, glaucoma, strabismus, and
retinal surgery with as many as 63% of patients having an under-
lying systemic disease.21 However, in recent years, there have been
several reports of necrotizing scleritis occurring after pterygium
surgery.22e25 In these case reports, none of the patients had an
associated autoimmune disease, despite a complete systemic
workup. In our series, all patients (n ¼ 8) with necrotizing scleritis
had a history of pterygium excision, and no patient had an under-
lying autoimmune disease. Ahn et al26 report ﬁndings similar to
ours, and found that 96.3% of their patients with necrotizing
scleritis had a previous pterygium excision surgery, whereas only
7.4% of patients had an underlying autoimmune disease. Autoim-
munity or delayed-hypersensitivity has been proposed as a possible
mechanism for surgically induced necrotizing scleritis,21 although
the mechanism in these pterygium surgery cases is probably more
related to localized ischemia at the surgical site that is promoted by
excessive cauterization during surgery.22
This study has several limitations. The major limitation is its
retrospective nature and the relatively small sample size. Further-
more, the results of our study need to be carefully interpreted
because this data was based on a single hospital experience, which
was not meant to represent the epidemiology of episcleritis and
scleritis in the entire Taiwanese population. Future study with a
representative sample size in a multi-institutional setting or a
population-based study is needed to provide further clariﬁcations
and insights into the results of our study. However, the strength of
our study is that it highlights the possible inﬂuence of geographic
regions and ethnicity on the presentation and etiology of scleritis.
In conclusion, we found that scleritis was a severe inﬂammatory
ocular disorder that occurs in the elderly population and is more
frequently associated with ocular complications, compared to
episcleritis. The most common presentations of scleritis in patients
who have had previous pterygium surgery were infectious scleritis
and necrotizing scleritis. The results of our study also suggest that
the occurrence of necrotizing scleritis may be greater in Southern
Taiwan than has previously been reported in the Westernpopulation. In our patients, the etiology may more likely be sur-
gically induced rather than autoimmune-associated.
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